Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: The ILUvien in Postoperative CYstoid Macular eDema Study.
Motloch K, Soler V, Delyfer MN, Vasseur V, Wolff B, Issa M, Dot C, Massé H, Weber M, Comet A, Hitzl W, Matonti F, Creuzot-Garcher C, Tadayoni R, Kodjikian L, Couturier A. Motloch K, et al. Among authors: creuzot garcher c. Ophthalmol Retina. 2024 Dec;8(12):1181-1191. doi: 10.1016/j.oret.2024.07.004. Epub 2024 Jul 14. Ophthalmol Retina. 2024. PMID: 39004282
Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P; RESTORE Extension Study Group. Schmidt-Erfurth U, et al. Ophthalmology. 2014 May;121(5):1045-53. doi: 10.1016/j.ophtha.2013.11.041. Epub 2014 Feb 1. Ophthalmology. 2014. PMID: 24491642 Free article. Clinical Trial.
European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice: Data from the Fight Retinal Blindness! Registry.
Boudousq C, Nguyen V, Hunt A, Gillies M, Zarranz-Ventura J, O'Toole L, Mangelschots E, Kusenda P, Schmidt-Erfurdt U, Pollreisz A, Kheir WJ, Arruabarrena C, Vujosevic S, Barthelmes D, Creuzot-Garcher C, Gabrielle PH. Boudousq C, et al. Ophthalmol Retina. 2024 Jun;8(6):527-536. doi: 10.1016/j.oret.2024.01.004. Epub 2024 Jan 6. Ophthalmol Retina. 2024. PMID: 38185453 Free article.
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! Registry.
Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, Kheir WJ, Kok G, Vujosevic S, O'Toole L, Mangelschots E, Jaross N, Ceklic L, Daien V, Viola F, Squirrell D, Lavid FJ, Creuzot-Garcher C, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group. Mehta H, et al. Ophthalmol Retina. 2024 Sep;8(9):872-879. doi: 10.1016/j.oret.2024.04.008. Epub 2024 Apr 16. Ophthalmol Retina. 2024. PMID: 38615818 Free article.
Pros and cons of internal limiting membrane peeling during epiretinal membrane surgery: a randomised clinical trial with microperimetry (PEELING).
Ducloyer JB, Eude Y, Volteau C, Lebreton O, Bonissent A, Fossum P, Tadayoni R, Creuzot-Garcher CP, Le Mer Y, Perol J, Fortin J, Jobert A, Billaud F, Ivan C, Poinas A, Weber M; CFSR Research Net. Ducloyer JB, et al. Br J Ophthalmol. 2024 Dec 17;109(1):119-125. doi: 10.1136/bjo-2023-324990. Br J Ophthalmol. 2024. PMID: 38901960 Free PMC article. Clinical Trial.
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V; Fight Retinal Blindness! Study Group. Debourdeau E, et al. Ophthalmol Ther. 2024 Sep;13(9):2343-2355. doi: 10.1007/s40123-024-00983-2. Epub 2024 Jul 8. Ophthalmol Ther. 2024. PMID: 38976148 Free PMC article.
A randomised study comparing performance and safety of Eyestil Plus® vs Vismed Multi® in moderate-to-severe dry eye syndrome patients.
Pisella PJ, Gain P, Cochener B, Baillif S, Kodjikian L, Creuzot-Garcher C, Touboul D, Gonzalvez M, Gabisson P, El Amali S, Galarreta D, Merayo Lloves J, Cano-Ortiz A, Ruiz Mesa R, Civiale C, Mazzone MG, Montero J. Pisella PJ, et al. Among authors: creuzot garcher c. Eur J Ophthalmol. 2024 Aug 2:11206721241266874. doi: 10.1177/11206721241266874. Online ahead of print. Eur J Ophthalmol. 2024. PMID: 39094552
Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.
Couret C, Quintart PA, Poinas A, Vibet MA, Le Lez ML, Labalette P, Bodaghi B, Labetoulle M, Rougier MB, Angioi K, Chiquet C, Titah C, Kodjikian L, Baillif S, Creuzot-Garcher C, Errera MH, Weber M. Couret C, et al. Among authors: creuzot garcher c. Br J Ophthalmol. 2025 Jan 28;109(2):215-222. doi: 10.1136/bjo-2023-325128. Br J Ophthalmol. 2025. PMID: 39168590 Clinical Trial.
382 results